MEDIFAST, Inc. (NY:MED)
17.54
+0.74 (4.40%)
| MEDIFAST, Inc. (NY:MED) Delayed : |
| Previous Close |
$16.80 |
|
52 Week High |
$36.58 |
|
| Open |
$17.23 |
|
52 Week Low |
$3.81 |
| Day High |
$17.90 |
|
P/E |
26.58 |
| Day Low |
$16.85 |
|
EPS |
$0.66 |
| Volume |
1,118,327 |
|
|
|
| More MED Info:
Chart
SEC Filings
Profile
Historical
Options
|
-
Jan 25, 2010 10:54 AM
Morning Movers 1/25: SMTX, NBS, ERI, KFS, PVTB, CADC Higher; PARD, SNEN, BBX, PCBC Lower
-
Jan 25, 2010 08:07 AM
Medifast (MED) Issues Q4, FY09 Outlook
-
Jan 20, 2010 08:26 AM
Medifast (MED) Affirmed as a Member of Good Standing by DSA
-
Jan 14, 2010 01:23 PM
Unusual 11 Mid-Day Movers 01/14: CRDC, GRAN, LAB, ETRM Higher; ROSG, MRNA, PEIX, MED Lower
-
Jan 14, 2010 12:40 PM
Medifast (MED) Defends Itself Against Minkow, Fraud Discovery Institute; Complaints Pending with DoJ, SEC
View All Reports
-
Feb 8, 2010 01:12PM
Medifast Adds Freshly Prepared Brownie to Meal Replacement Line
-
Jan 25, 2010 08:00AM
Medifast Reports Record Preliminary Fourth Quarter and Year End 2009 Financial Results
-
Jan 20, 2010 08:00AM
Direct Selling Association Reaffirms Membership in Good Standing of Medifast, Inc./Take Shape for Life and the Company's Commitment to 'High Ethical Standards'
-
Jan 14, 2010 05:16PM
Medifast, Inc. Complaints Against FDI Pending With the United States Department of Justice, the United States Securities and Exchange Commission, the Maryland Securities Commissioner
-
Jan 14, 2010 12:36PM
Medifast, Inc. Complaints Pending With the United States Department of Justice, the United States Securities and Exchange Commission, the Maryland Securities Commissioner
View All Press Releases
StreetInsider Reports on MED by Category
Comments on recent MED articles
Comments on MED
No comments are currently available.
on Sep 11, 2009
at 02:01 PM Medifast Stock at $19 The TSFL Multi-Level marketing will not win the day on YOY growth rates Medifast sports with a 40 PE at $19 a share. Major dilution underway. Medifast stock is risky speculation.
Article: Stocklemon.com issue negative report on Medifast (MED)
on Jun 10, 2009
at 02:16 PM MED DownGrade Medifast (NYSE – MED) downgraded due to insider trades, poor Auditor transparency/conflicts and potential risk that their recent Revenue reporting may be revised down. .This is going to get much worse before it gets better –going down to $5.00 So the Chairman’s household sold a cool Million dollars worth of the stock in the last round – Each share sold under the knowledge of an investigation into MED and its revenue recognition categories. “Brad” has been out posting again, a disclosure and dissemination of inside information in violation of SEC rules prohibiting such “insider” communications. (Whole Foods CEO ring a bell?) Minkow is not going away and appears to have made real headway with the Auditor conflict – (Selling shares or not – owning a brokerage house is the real conflict) I am asking here – does anyone know of an auditor of publicly traded companies, who also owns a Brokerage company too? I can’t find one at all! MED’s miraculous revenue increase last Q, - was mandatory to get MED off the NYSE’s dreaded “Watch List”. This revenue recognition was masterminded by the Chairman and the conflicted Auditor – it may have to be revised…. (What is the NYSE’s internal control doing about this too?)
Article: Medifast (MED) Chairman's Wife Cashes In Over $1M In Stock